Can Intravenous Antifungal therapy be safely used in the Outpatient Parenteral Antimicrobial Therapy (OPAT) setting?

Nikolas Rae, Claire Kenny, Eavan G. Muldoon (Lead / Corresponding author)

    Research output: Contribution to journalReview article

    17 Downloads (Pure)

    Abstract

    Outpatient parenteral antimicrobial therapy (OPAT) is an established treatment option for patients with a variety of infections who require a period of intravenous therapy, are clinically stable, and do not require continuous monitoring. Many patients with fungal infections require prolonged therapy due to resistance or intolerance to oral antifungal agents. Despite the widespread use of OPAT by infection specialists, antifungal agents appear infrequently used in this setting. We suggest that with appropriate patient selection, patients with fungal infections could successfully be treated on OPAT. This article is protected by copyright. All rights reserved.

    Original languageEnglish
    Pages (from-to)196-203
    Number of pages8
    JournalMycoses
    Volume62
    Issue number3
    Early online date30 Nov 2018
    DOIs
    Publication statusPublished - Mar 2019

    Fingerprint

    Outpatients
    Mycoses
    Antifungal Agents
    Therapeutics
    Infection
    Patient Selection

    Keywords

    • OPAT
    • antifungal
    • parenteral antifungal therapy
    • invasive candidosis
    • patient safety
    • outpatient parenteral antimicrobial therapy

    Cite this

    @article{f4f397715b494defb0f03e0219191907,
    title = "Can Intravenous Antifungal therapy be safely used in the Outpatient Parenteral Antimicrobial Therapy (OPAT) setting?",
    abstract = "Outpatient parenteral antimicrobial therapy (OPAT) is an established treatment option for patients with a variety of infections who require a period of intravenous therapy, are clinically stable, and do not require continuous monitoring. Many patients with fungal infections require prolonged therapy due to resistance or intolerance to oral antifungal agents. Despite the widespread use of OPAT by infection specialists, antifungal agents appear infrequently used in this setting. We suggest that with appropriate patient selection, patients with fungal infections could successfully be treated on OPAT. This article is protected by copyright. All rights reserved.",
    keywords = "OPAT, antifungal, parenteral antifungal therapy, invasive candidosis, patient safety, outpatient parenteral antimicrobial therapy",
    author = "Nikolas Rae and Claire Kenny and Muldoon, {Eavan G.}",
    note = "No Funding.",
    year = "2019",
    month = "3",
    doi = "10.1111/myc.12874",
    language = "English",
    volume = "62",
    pages = "196--203",
    journal = "Mycoses",
    issn = "0933-7407",
    publisher = "Wiley",
    number = "3",

    }

    Can Intravenous Antifungal therapy be safely used in the Outpatient Parenteral Antimicrobial Therapy (OPAT) setting? / Rae, Nikolas; Kenny, Claire; Muldoon, Eavan G. (Lead / Corresponding author).

    In: Mycoses, Vol. 62, No. 3, 03.2019, p. 196-203.

    Research output: Contribution to journalReview article

    TY - JOUR

    T1 - Can Intravenous Antifungal therapy be safely used in the Outpatient Parenteral Antimicrobial Therapy (OPAT) setting?

    AU - Rae, Nikolas

    AU - Kenny, Claire

    AU - Muldoon, Eavan G.

    N1 - No Funding.

    PY - 2019/3

    Y1 - 2019/3

    N2 - Outpatient parenteral antimicrobial therapy (OPAT) is an established treatment option for patients with a variety of infections who require a period of intravenous therapy, are clinically stable, and do not require continuous monitoring. Many patients with fungal infections require prolonged therapy due to resistance or intolerance to oral antifungal agents. Despite the widespread use of OPAT by infection specialists, antifungal agents appear infrequently used in this setting. We suggest that with appropriate patient selection, patients with fungal infections could successfully be treated on OPAT. This article is protected by copyright. All rights reserved.

    AB - Outpatient parenteral antimicrobial therapy (OPAT) is an established treatment option for patients with a variety of infections who require a period of intravenous therapy, are clinically stable, and do not require continuous monitoring. Many patients with fungal infections require prolonged therapy due to resistance or intolerance to oral antifungal agents. Despite the widespread use of OPAT by infection specialists, antifungal agents appear infrequently used in this setting. We suggest that with appropriate patient selection, patients with fungal infections could successfully be treated on OPAT. This article is protected by copyright. All rights reserved.

    KW - OPAT

    KW - antifungal

    KW - parenteral antifungal therapy

    KW - invasive candidosis

    KW - patient safety

    KW - outpatient parenteral antimicrobial therapy

    UR - http://www.scopus.com/inward/record.url?scp=85060525682&partnerID=8YFLogxK

    U2 - 10.1111/myc.12874

    DO - 10.1111/myc.12874

    M3 - Review article

    C2 - 30499620

    VL - 62

    SP - 196

    EP - 203

    JO - Mycoses

    JF - Mycoses

    SN - 0933-7407

    IS - 3

    ER -